Donidalorsen: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Donidalorsen. Educational only — not medical advice.
Labeled uses
DAWNZERA™ is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
Source: FDA labeling via NIH DailyMed (set 3ff501e0…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.